We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

25 hedge funds and large institutions have $3.56M invested in Sophiris Bio, Inc. in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

81% more capital invested

Capital invested by funds: $1.97M → $3.56M (+$1.59M)

14% more funds holding

Funds holding: 22 → 25 (+3)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.59M
2
VF
Virtu Financial
New York
+$52.8K
3
PAG
Private Advisor Group
New Jersey
+$17.8K
4
Victory Capital Management
Victory Capital Management
Texas
+$4.51K
5
Barclays
Barclays
United Kingdom
+$1.2K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$45K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$21.3K
3
ARTA
A.R.T. Advisors
New York
-$12K
4
Jane Street
Jane Street
New York
-$10K
5
Bank of America
Bank of America
North Carolina
-$2.17K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$2.21M +$1.59M +1,793,666 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$728K -$21.3K -23,929 -2%
HP
3
Hikari Power
Japan
$176K – – –
PAI
4
Palo Alto Investors
California
$144K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$142K – – –
Northern Trust
6
Northern Trust
Illinois
$41K – – –
VF
7
Virtu Financial
New York
$35K +$52.8K +59,469 New
BO
8
BRR OpCo
Ohio
$23K – – –
ACM
9
Alpha Capital Management
Texas
$20K – – –
PAG
10
Private Advisor Group
New Jersey
$12K +$17.8K +20,000 New
LPL Financial
11
LPL Financial
California
$6K – – –
AG
12
Advisor Group
Arizona
$4K – – –
ACM
13
AUA Capital Management
Pennsylvania
$4K – – –
UBS Group
14
UBS Group
Switzerland
$3K -$1.39K -1,560 -22%
Morgan Stanley
15
Morgan Stanley
New York
$3K – – –
Victory Capital Management
16
Victory Capital Management
Texas
$3K +$4.51K +5,073 New
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$1K – – –
Group One Trading
18
Group One Trading
Illinois
$1K – – –
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$1K – – –
Barclays
20
Barclays
United Kingdom
$1K +$1.2K +1,353 New
FDCDDQ
21
Federation des caisses Desjardins du Quebec
Quebec, Canada
$106 – – –
SM
22
Sabby Management
Florida
– -$45K -52,685 Closed
ARTA
23
A.R.T. Advisors
New York
– -$12K -14,704 Closed
Jane Street
24
Jane Street
New York
– -$10K -11,707 Closed
Bank of America
25
Bank of America
North Carolina
– -$2.17K -2,441 -84%
1
2

SPHS Hedge Fund Activity: Q3 2019 in Review

25 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2019, worth a combined $3.56M — up 81% from $1.97M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SPHS positions and 3 closed out — a net gain of 3 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.59M. The largest seller was Sabby Management, exiting entirely with an estimated $45K sold.

  • 25 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2019, up from 22 in Q2 2019.
  • Funds reported $3.56M of Sophiris Bio, Inc. stock for Q3 2019, up 81% quarter-over-quarter.
  • 6 funds opened new Sophiris Bio, Inc. positions in Q3 2019 and 3 closed out, a net change of +3 holders.
  • The largest Sophiris Bio, Inc. buyer in Q3 2019 was Armistice Capital, an estimated $1.59M added.
  • The largest Sophiris Bio, Inc. seller in Q3 2019 was Sabby Management, an estimated $45K sold.

Based on aggregated 13F filings for Q3 2019.